Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries.

Navamedic ASA: Invitation to 2025 2nd quarter presentation

Navamedic ASA: Closing of the transaction to acquire the business of dne pharma

Navamedic ASA – Minutes of Extraordinary General Meeting

Navamedic ASA – Additional underwriting commitments in the Rights Issue

Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product